A detailed history of Landscape Capital Management, L.L.C. transactions in Exelixis, Inc. stock. As of the latest transaction made, Landscape Capital Management, L.L.C. holds 27,770 shares of EXEL stock, worth $1.01 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
27,770
Holding current value
$1.01 Million
% of portfolio
0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$21.96 - $27.6 $609,829 - $766,452
27,770 New
27,770 $720,000
Q1 2019

May 15, 2019

SELL
$19.6 - $24.76 $766,379 - $968,140
-39,101 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$13.65 - $21.8 $533,728 - $852,401
39,101 New
39,101 $769,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Landscape Capital Management, L.L.C. Portfolio

Follow Landscape Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.